| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |